VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Janssen-Cilag S.p.A.
Information provided by (Responsible Party):
Michele Cavo, Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
ClinicalTrials.gov Identifier:
NCT01134484
First received: May 28, 2010
Last updated: July 19, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
No publications provided by Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):